265 related articles for article (PubMed ID: 20601385)
1. Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts.
Tang M; Li J; Huang W; Su H; Liang Q; Tian Z; Horak KM; Molkentin JD; Wang X
Cardiovasc Res; 2010 Dec; 88(3):424-33. PubMed ID: 20601385
[TBL] [Abstract][Full Text] [Related]
2. Too much of a good thing is bad: proteasome inhibition induces stressed hearts to fail.
Carrier L
Cardiovasc Res; 2010 Dec; 88(3):389-90. PubMed ID: 20889761
[No Abstract] [Full Text] [Related]
3. Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice.
Oliveira RS; Ferreira JC; Gomes ER; Paixão NA; Rolim NP; Medeiros A; Guatimosim S; Brum PC
J Physiol; 2009 Aug; 587(Pt 15):3899-910. PubMed ID: 19505981
[TBL] [Abstract][Full Text] [Related]
4. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation.
Donaldson C; Eder S; Baker C; Aronovitz MJ; Weiss AD; Hall-Porter M; Wang F; Ackerman A; Karas RH; Molkentin JD; Patten RD
Circ Res; 2009 Jan; 104(2):265-75, 11p following 275. PubMed ID: 19074476
[TBL] [Abstract][Full Text] [Related]
5. Does contractile Ca2+ control calcineurin-NFAT signaling and pathological hypertrophy in cardiac myocytes?
Houser SR; Molkentin JD
Sci Signal; 2008 Jun; 1(25):pe31. PubMed ID: 18577756
[TBL] [Abstract][Full Text] [Related]
6. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo.
Grebe C; Klingebiel TM; Grau SP; Toischer K; Didié M; Jacobshagen C; Dullin C; Hasenfuss G; Seidler T
Cardiovasc Res; 2011 Jun; 90(3):521-8. PubMed ID: 21273244
[TBL] [Abstract][Full Text] [Related]
8. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
[TBL] [Abstract][Full Text] [Related]
9. The Calcineurin-TFEB-p62 Pathway Mediates the Activation of Cardiac Macroautophagy by Proteasomal Malfunction.
Pan B; Li J; Parajuli N; Tian Z; Wu P; Lewno MT; Zou J; Wang W; Bedford L; Mayer RJ; Fang J; Liu J; Cui T; Su H; Wang X
Circ Res; 2020 Jul; 127(4):502-518. PubMed ID: 32366200
[TBL] [Abstract][Full Text] [Related]
10. Stachydrine hydrochloride suppresses phenylephrine-induced pathological cardiac hypertrophy by inhibiting the calcineurin/nuclear factor of activated T-cell signalling pathway.
Zheng J; Tian J; Wang S; Hu P; Wu Q; Shan X; Zhao P; Zhang C; Guo W; Xu M; Chen H; Lu R
Eur J Pharmacol; 2020 Sep; 883():173386. PubMed ID: 32712088
[TBL] [Abstract][Full Text] [Related]
11. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
[TBL] [Abstract][Full Text] [Related]
12. Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy.
Lunde IG; Aronsen JM; Melleby AO; Strand ME; Skogestad J; Bendiksen BA; Ahmed MS; Sjaastad I; Attramadal H; Carlson CR; Christensen G
Mol Biol Rep; 2022 Dec; 49(12):11795-11809. PubMed ID: 36205855
[TBL] [Abstract][Full Text] [Related]
13. Cooperative Binding of ETS2 and NFAT Links Erk1/2 and Calcineurin Signaling in the Pathogenesis of Cardiac Hypertrophy.
Luo Y; Jiang N; May HI; Luo X; Ferdous A; Schiattarella GG; Chen G; Li Q; Li C; Rothermel BA; Jiang D; Lavandero S; Gillette TG; Hill JA
Circulation; 2021 Jul; 144(1):34-51. PubMed ID: 33821668
[TBL] [Abstract][Full Text] [Related]
14. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy.
Wilkins BJ; Dai YS; Bueno OF; Parsons SA; Xu J; Plank DM; Jones F; Kimball TR; Molkentin JD
Circ Res; 2004 Jan; 94(1):110-8. PubMed ID: 14656927
[TBL] [Abstract][Full Text] [Related]
15. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways.
Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J
Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128
[TBL] [Abstract][Full Text] [Related]
16. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.
Braz JC; Bueno OF; Liang Q; Wilkins BJ; Dai YS; Parsons S; Braunwart J; Glascock BJ; Klevitsky R; Kimball TF; Hewett TE; Molkentin JD
J Clin Invest; 2003 May; 111(10):1475-86. PubMed ID: 12750397
[TBL] [Abstract][Full Text] [Related]
17. Isoform- and tissue-specific regulation of the Ca(2+)-sensitive transcription factor NFAT in cardiac myocytes and heart failure.
Rinne A; Kapur N; Molkentin JD; Pogwizd SM; Bers DM; Banach K; Blatter LA
Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2001-9. PubMed ID: 20304816
[TBL] [Abstract][Full Text] [Related]
18. MAFbx/Atrogin-1 is required for atrophic remodeling of the unloaded heart.
Baskin KK; Rodriguez MR; Kansara S; Chen W; Carranza S; Frazier OH; Glass DJ; Taegtmeyer H
J Mol Cell Cardiol; 2014 Jul; 72():168-76. PubMed ID: 24650875
[TBL] [Abstract][Full Text] [Related]
19. CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes.
MacDonnell SM; Weisser-Thomas J; Kubo H; Hanscome M; Liu Q; Jaleel N; Berretta R; Chen X; Brown JH; Sabri AK; Molkentin JD; Houser SR
Circ Res; 2009 Aug; 105(4):316-25. PubMed ID: 19608982
[TBL] [Abstract][Full Text] [Related]
20. GSK-3β/NFAT Signaling Is Involved in Testosterone-Induced Cardiac Myocyte Hypertrophy.
Duran J; Oyarce C; Pavez M; Valladares D; Basualto-Alarcon C; Lagos D; Barrientos G; Troncoso MF; Ibarra C; Estrada M
PLoS One; 2016; 11(12):e0168255. PubMed ID: 27977752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
